From a clinical standpoint, a recent study exploring a strategy to treat hypercholesterolemia showed that targeting of the low-density lipoprotein receptor (LDLR) by dsRNAs activated its expression and increased display on the surfaces of liver cells [11]. Here, LDLR is linked to Hypercholesterolemia.